This disclosure general relates to substrates for culturing cells and fixed bed bioreactors incorporating such substrates. In particular, the present disclosure relates to fixed beds having a mixture of cell culture substrates and bioreactors with such fixed beds having uniform fluid flow characteristics.
In the bioprocessing industry, large-scale cultivation of cells is performed for purposes of the production of hormones, enzymes, antibodies, vaccines, and cell therapies. Cell and gene therapy markets are growing rapidly, with promising treatments moving into clinical trials and quickly toward commercialization. However, one cell therapy dose can require billions of cells or trillions of viruses. As such, being able to provide a large quantity of cell or virus products in a short amount of time is critical for clinical success.
A significant portion of the cells used in bioprocessing are anchorage dependent, meaning the cells need a surface to adhere to for growth and functioning. Traditionally, the culturing of adherent cells is performed on two-dimensional (2D) cell-adherent surfaces incorporated in one of a number of vessel formats, such as T-flasks, petri dishes, cell factories, cell stack vessels, roller bottles, and HYPERStack® vessels. These approaches can have significant drawbacks, including the difficulty in achieving cellular density high enough to make it feasible for large scale production of therapies or cells.
Alternative methods have been suggested to increase volumetric density of cultured cells. These include microcarrier cultures performed in stir tanks. In this approach, cells that are attached to the surface of microcarriers are subject to constant shear stress, resulting in a significant impact on proliferation and culture performance. Another example of a high-density cell culture system is a hollow fiber bioreactor, in which cells may form large three-dimensional aggregates as they proliferate in the interspatial fiber space. However, the cells growth and performance are significantly inhibited by the lack nutrients. To mitigate this problem, these bioreactors are made small and are not suitable for large scale manufacturing
Another example of a high-density culture system for anchorage dependent cells is a packed-bed bioreactor system. In this this type of bioreactor, a cell substrate is randomly packed into a bioreactor vessel and used to provide a surface for the attachment of adherent cells. Media is perfused along the surface or through the packed bed to provide nutrients and oxygen needed for cell growth. For example, packed bed bioreactor systems that contain a packed bed to entrap the cells have been previously disclosed U.S. Pat. Nos. 4,833,083; 5,501,971; and 5,510,262. Packed bed matrices usually are made of porous particles as substrates or non-woven microfibers of polymer. Such bioreactors function as recirculation flow-through bioreactors. One of the significant issues with such bioreactors is the non-uniformity of cell distribution inside the packed bed. For example, the packed bed functions as depth filter with cells predominantly trapped at the inlet regions, resulting in a gradient of cell distribution during the inoculation step. In addition, due to random fiber packaging, flow resistance and cell trapping efficiency of cross sections of the packed bed are not uniform. For example, medium flows fast though the regions with low cell packing density and flows slowly through the regions where resistance is higher due to higher number of entrapped cells. This creates a channeling effect where nutrients and oxygen are delivered more efficiently to regions with lower volumetric cells densities and regions with higher cell densities are being maintained in suboptimal culture conditions.
Another significant drawback of packed bed systems disclosed in a prior art is the inability to efficiently harvest intact viable cells at the end of culture process. Harvesting of cells is important if the end product is cells, or if the bioreactor is being used as part of a “seed train,” where a cell population is grown in one vessel and then transferred to another vessel for further population growth. U.S. Pat. No. 9,273,278 discloses a bioreactor design to improve the efficiency of cell recovery from the packed bed during cells harvesting step. It is based on loosening the packed bed matrix and agitation or stirring of packed bed particles to allow porous matrices to collide and thus detach the cells. However, this approach is laborious and may cause significant cells damage, thus reducing overall cell viability.
For example, some packed bed bioreactors use small strips of cell substrate material consisting of randomly oriented fibers in a non-woven arrangement. These strips are packed into a vessel to create a packed bed. However, non-uniform packing of the substrate strips can create visible channels within the packed bed, leading to preferential and non-uniform media flow and nutrient distribution through the packed bed. Studies of such systems have noted a “systemic inhomogeneous distribution of cells, with their number increasing from top to bottom of fixed bed,” as well as a “nutrient gradient . . . leading to restricted cell growth and production,” all of which lead to the “unequal distribution of cells [that] may impair transfection efficiency.” (Rational plasmid design and bioprocess optimization to enhance recombinant adeno-associated virus (AAV) productivity in mammalian cells. Biotechnol. J. 2016, 11, 290-297). Studies have noted that agitation of the packed bed may improve dispersion, but would have other drawbacks (i.e., “necessary agitation for better dispersion during inoculation and transfection would induce increased shear stress, in turn leading to reduced cell viability.” Id.). Another study noted that the uneven distribution of cells makes monitoring of the cell population using biomass sensors difficult (“ . . . if the cells are unevenly distributed, the biomass signal from the cells on the top carriers may not show the general view of the entire bioreactor.” Process Development of Adenoviral Vector Production in Fixed Bed Bioreactor: From Bench to Commercial Scale. Human Gene Therapy, Vol. 26, No. 8, 2015).
In addition, because of the random arrangement of fibers in the substrate strips and the variation in packing of strips between one packed bed and another of a given packed bed reactor system, it can be difficult for users to predict cell culture performance, since the substrate varies between cultures. Furthermore, the packed substrate of many existing bioreactors makes efficiently harvesting cells very difficult or impossible, as it is believed that cells are entrapped by the packed bed.
There is a need for a platform that can produce high-quality cell and virus products in greater numbers in order to reach late-stage commercial manufacturing scale. In particular, there is a need for cell culture substrates and/or matrices, bioreactors, systems, and methods that enable culturing of cells in a high-density format, with uniform cell distribution, improved and uniform fluid flow characteristics, and easily attainable and increased harvesting yields.
According to embodiments of this disclosure, a cell culture matrix for culturing cells in a fixed bed reactor is provided. The cell culture matrix comprises a plurality of substrate layers in a stacked arrangement of parallel layers, each layer of the plurality of substrate layers comprising a substrate material with an ordered and regular array of openings passing through the layer. The openings are separated by the substrate material having a physical structure that is substantially regular and uniform and that is configured for growing cell thereon. The plurality of substrate layers comprises a first substrate material and a second substrate material that is different from the first substrate material in at least one physical dimension. The first substrate material and the second substrate material are separate layers of the plurality of substrate layers.
According to aspects of embodiments of this disclosure, the at least one physical dimension is at least one of a diameter of the openings, a thickness of the physical structure, a pattern of the physical structure, and a spacing of the physical structure on either side of an opening. The physical structure can comprise a plurality of fibers. In embodiments, the plurality of fibers comprises a first plurality of fibers running parallel to each other in a first direction, and a second plurality of fibers running parallel to each other in a second direction that is different from the first direction. In embodiments, the at least one physical dimension is a fiber spacing between two neighboring fibers of the plurality of fibers. A ratio of the fiber spacing of the first substrate material to the fiber spacing of the second substrate material is greater than 1.0, about 1.2 or greater, about 1.4 or greater, about 1.6 or greater, about 1.8 or greater, or from about 1.4 to about 1.8. A degree of relative rotation between the first substrate material and the second substrate material can be random. The first substrate material and the second substrate material are stacked as alternating layers of the plurality of substrate layers, according to aspects of some embodiments. In embodiments, variation in flow rate of fluid flowing through the cell culture matrix is uniform across a width of the cell culture matrix, the width being in a direction perpendicular to a direction of fluid flow.
According to embodiments of this disclosure, a bioreactor system for culturing cells is provided. The system comprises a cell culture vessel comprising at least one interior reservoir, an inlet fluidly connected to the reservoir, and an outlet fluidly connected to the reservoir; and the cell culture matrix described above, where the cell culture matrix is disposed in the reservoir.
According to aspects of embodiments, the bioreactor system is configured for perfusion flow through the cell culture matrix during cell culture. The bioreactor system can also be configured to harvest viable cells from the cell culture matrix within the reservoir.
According to embodiments of this disclosure, a cell culture matrix for culturing cells in a fixed bed reactor is provided, where the cell culture matrix comprises: a plurality of substrate layers in a stacked arrangement of parallel layers, each layer of the plurality of substrate layers comprising a plurality of interwoven fibers configured for culturing cells thereon, and an ordered and regular array of openings defined by the plurality of interwoven fibers and passing through the layer, wherein each layer of the plurality of substrate layers is rotated about a center of the layer relative to an immediately neighboring layer in the stack. According to aspects of embodiments, a degree of the rotation is about 20° or greater, about 20° to about 45°, about 30° to about 45°, or about 45°.
Various embodiments of the disclosure will be described in detail with reference to drawings, if any. Reference to various embodiments does not limit the scope of the invention, which is limited only by the scope of the claims attached hereto. Additionally, any examples set forth in this specification are not limiting and merely set forth some of the many possible embodiments of the claimed invention.
Embodiments of this disclosure include fixed bed cell culture substrates, as well as cell culture or bioreactor systems incorporating such a substrate. The substrates, and bioreactor systems incorporating the same, exhibit improved flow characteristics through the substrate. For example, more uniform flow is achieved through the substrate, and non-uniform flow resulting from channeling or turbulent flow is reduced or eliminated. Flow “dead zones” in the substrate or fixed bed of the bioreactor are greatly reduced or eliminated compared to alternative solutions. The result is a substrate or fixed bed that allows for uniform perfusion throughout the substrate or fixed bed, which promotes cell health during cell culture and an efficient cell culture process in terms of not only the culturing of cells, but also cell seeding, and harvesting of cells or cell by-products.
Embodiments of this disclosure also include fixed bed substrates and bioreactors that enable simplified and more efficient manufacturing and assembly. For example, embodiments include fixed bed cell culture substrates that must be assembled from one or more pieces of substrate, as well as bioreactors in which such fixed bed cell culture substrates are placed. Aspects of embodiments of this disclosure allow for such assembly of the fixed bed and/or placement of the fixed bed into reactor to be simplified by reducing the degree to which pieces of the cell culture substrate must be aligned with one another, which reduces the need for complicated procedures for handling and assembling the fixed bed, or the need for complicated mechanisms in the bioreactor to maintain particular orientations or alignments of the fixed bed. This reduction in complexity can translate to faster and cheaper manufacturing, shipping, and assembly, and more reliable bioreactors.
Aspects of embodiments also include fixed bed substrate matrices and bioreactors that provide more uniform fluid flow through the cell culture substrate fixed bed.
In conventional large-scale cell culture bioreactors, different types of fixed bed or packed bed bioreactors have been used. Usually these packed beds contain porous matrices to retain adherent or suspension cells, and to support growth and proliferation. Packed-bed matrices provide high surface area to volume ratios, so cell density can be higher than in the other systems. However, the packed bed often functions as a depth filter, where cells are physically trapped in the entangled fibers of the matrix. Thus, because of linear flow of the cell inoculum through the packed bed, cells are subject to heterogeneous distribution inside the packed bed, leading to variations in cell density through the depth or width of the packed bed. For example, cell density may be higher at the inlet region of a bioreactor and significantly lower nearer to the outlet of the bioreactor. This non-uniform distribution of the cells inside of the packed bed significantly hinders scalability and predictability of such bioreactors in bioprocess manufacturing, and can even lead to reduced efficiency in terms of growth of cells or viral vector production per unit surface area or volume of the packed bed.
Another problem encountered in packed bed bioreactors disclosed in prior art is the channeling effect. Due to random nature of packed nonwoven fibers, the local fiber density at any given cross section of the packed bed is not uniform. Liquid media flows quickly in the regions with low fiber density (high bed permeability) and much slower in the regions of high fiber density (lower bed permeability). The resulting non-uniform media perfusion across the packed bed creates the channeling effect, which manifests itself as significant nutrient and metabolite gradients that negatively impact overall cell culture and bioreactor performance. Cells located in the regions of low media perfusion will starve and very often die from the lack of nutrients or metabolite poisoning. The flow can be so non-uniform that there are effectively flow “dead zones” in the packed bed, where perfusion does not occur and the delivery of any nutrients to cells in those areas is limited to diffusion mechanics in the media.
Cell harvesting is yet another problem encountered when bioreactors packed with non-woven fibrous scaffolds are used. Due to packed-bed functions as depth filter, cells that are released at the end of cell culture process are entrapped inside the packed bed, and cell recovery is very low. This significantly limits utilization of such bioreactors in bioprocesses where live cells are the products or where live cells need to be harvested for further processing to capture cell by-products. Thus, the non-uniformity leads to areas with different exposure to flow and shear, effectively reducing the usable cell culture area, causing non-uniform culture, and interfering with transfection efficiency and cell release.
To address these and other problems of existing cell culture solutions, embodiments of the present disclosure provide cell growth substrates, fixed bed assemblies of such substrates, and/or bioreactor systems using such substrates that enable efficient and high-yield cell culturing for anchorage-dependent cells and production of cell products (e.g., proteins, antibodies, viral particles) with simplified manufacture and assembly of the fixed bed. Embodiments include a porous cell-culture matrix made from an ordered and regular array of porous substrate material that enables uniform cell seeding and media/nutrient perfusion, as well as efficient cell harvesting. Embodiments also enable scalable cell-culture solutions with substrates and bioreactors capable of seeding and growing cells and/or harvesting cell products from a process development scale to a full production size scale, without sacrificing the uniform performance of the embodiments. For example, in some embodiments, a bioreactor can be easily scaled from process development scale to product scale with comparable viral genome per unit surface area of substrate (VG/cm2) across the production scale. The harvestability and scalability of the embodiments herein enable their use in efficient seed trains for growing cell populations at multiple scales on the same cell substrate. In addition, the embodiments herein provide a cell culture matrix having a high surface area that, in combination with the other features described, enables a high yield cell culture solution. In some embodiments, for example, the cell culture substrate and/or bioreactors discussed herein can produce 1016 to 1018 viral genomes (VG) per batch.
In one embodiment, a matrix is provided with a structurally defined surface area for adherent cells to attach and proliferate that has good mechanical strength and forms a highly uniform multiplicity of interconnected fluidic networks when assembled in a packed bed or other bioreactor. In particular embodiments, a mechanically stable, non-degradable woven mesh can be used as the substrate to support adherent cell production. The cell culture matrix disclosed herein supports attachment and proliferation of anchorage dependent cells in a high volumetric density format. Uniform cell seeding of such a matrix is achievable, as well as efficient harvesting of cells or other products of the bioreactor. In addition, the embodiments of this disclosure support cell culturing to provide uniform cell distribution during the inoculation step and achieve a confluent monolayer or multilayer of adherent cells on the disclosed matrix, and can avoid formation of large and/or uncontrollable 3D cellular aggregates with limited nutrient diffusion and increased metabolite concentrations. Thus, the matrix eliminates diffusional limitations during operation of the bioreactor. In addition, the matrix enables easy and efficient cell harvest from the bioreactor. The structurally defined matrix of one or more embodiments enables complete cell recovery and consistent cell harvesting from the packed bed of the bioreactor.
In contrast to existing cell culture substrates used in cell culture bioreactors (e.g., non-woven substrates of randomly ordered fibers), embodiments of this disclosure include cell culture substrates having defined and ordered structures. The defined and order structure allows for consistent and predictable cell culture results. In addition, the substrates have open porous structures that prevent cell entrapment and enables uniform flow through the packed bed. This construction enables improved cell seeding, nutrient delivery, cell growth, and cell harvesting. According to one or more particular embodiments, the fixed bed matrix is formed with at least one substrate material having a thin, sheet-like construction having first and second sides separated by a relatively small thickness, such that the thickness of the sheet is small relative to the width and/or length of the first and second sides of the substrate. In addition, a plurality of holes or openings are formed through the thickness of the substrate. The substrate material between the openings is of a size and geometry that allows cells to adhere to the surface of the substrate material as if it were approximately a two-dimensional (2D) surface, while also allowing adequate fluid flow around the substrate material and through the openings. In some embodiments, the substrate is a polymer-based material, and can be formed as a molded polymer sheet; a polymer sheet with openings punched through the thickness; a number of filaments that are fused into a mesh-like layer; a 3D-printed substrate; or a plurality of filaments that are woven into a mesh layer. The physical structure of the fixed bed matrix has a high surface-to-volume ratio for culturing anchorage dependent cells. According to various embodiments, the fixed bed matrix can be arranged or packed in a bioreactor in certain ways discussed herein for uniform cell seeding and growth, uniform media perfusion, efficient cell harvest, and simplified manufacturing and packaging.
Embodiments of this disclosure can achieve viral vector platforms of a practical size that can produce viral genomes on the scale of greater than about 1014 viral genomes per batch, greater than about 1015 viral genomes per batch, greater than about 1016 viral genomes per batch, greater than about 1017 viral genomes per batch, or up to or greater than about g 1016 viral genomes per batch. In some embodiments, productions is about 1015 to about 1018 or more viral genomes per batch. For example, in some embodiments, the viral genome yield can be about 1015 to about 1016 viral genomes or batch, or about 1016 to about 1019 viral genomes per batch, or about 1016-1018 viral genomes per batch, or about 1017 to about 1019 viral genomes per batch, or about 1018 to about 1019 viral genomes per batch, or about 1018 or more viral genomes per batch.
In addition, the embodiments disclosed herein enable not only cell attachment and growth to a cell culture substrate, but also the viable harvest of cultured cells. The inability to harvest viable cells is a significant drawback in current platforms, and it leads to difficulty in building and sustaining a sufficient number of cells for production capacity. According to an aspect of embodiments of this disclosure, it is possible to harvest viable cells from the cell culture substrate, including between 80% to 100% viable, or about 85% to about 99% viable, or about 90% to about 99% viable. For example, of the cells that are harvested, at least 80% are viable, at least 85% are viable, at least 90% are viable, at least 91% are viable, at least 92% are viable, at least 93% are viable, at least 94% are viable, at least 95% are viable, at least 96% are viable, at least 97% are viable, at least 98% are viable, or at least 99% are viable. Cells may be released from the cell culture substrate using, for example, trypsin, TrypLE, or Accutase.
The woven fibers of the substrate 100 form a plurality of openings 106, which can be defined by one or more widths or diameters (e.g., D1, D2). The size and shape of the openings can vary based on the type of weave (e.g., number, shape and size of filaments; angle between intersecting filaments, etc.). A woven mesh may be characterized as, on a macro-scale, a two-dimensional sheet or layer. However, a close inspection of a woven mesh reveals a three-dimensional structure due to the rising and falling of intersecting fibers of the mesh. Thus, as shown in
In
A given fiber of the first plurality of fibers 102 has a thickness t1, and a given fiber of the second plurality of fibers 104 has a thickness t2. In the case of fibers of round cross-section, as shown in
In one or more embodiments, a fiber may have a diameter in a range of about 10 μm to about 1000 μm; about 10 μm to about 750 μm; about 15 μm to about 600 μm; about 150 μm to about 500 μm; about 20 μm to about 400 μm; about 30 μm to about 325 μm; from about 15 μm to about 200 μm; or about 150 μm to about 300 μm. On a microscale level, due to the scale of the fiber compared to the cells (e.g., the fiber diameters being larger than the cells), the surface of monofilament fiber is presented as an approximation of a 2D surface for adherent cells to attach and proliferate. Fibers can be woven into a mesh with openings ranging from about 100 μm×100 μm to about 1000 μm×1000 μm. In some embodiments, the opening may have a diameter of about 20 μm to about 1000 μm; about 100 μm to about 750 μm; about 125 μm to about 600 μm; about 150 μm to about 500 μm; about 200 μm to about 400 μm; or about 200 μm to about 300 μm; from about 40 μm to about 900 μm, from about 50 μm to about 300 μm, or from about 225 μm to about 800 μm. These ranges of the filament diameters and opening diameters are examples of some embodiments, but are not intended to limit the possible feature sizes of the mesh according to all embodiments. The combination of fiber diameter and opening diameter is chosen to provide efficient and uniform fluid flow through the substrate when, for example, the fixed bed cell culture matrix comprises a number of adjacent mesh layers (e.g., a stack of individual layers or a rolled mesh layer).
Factors such as the fiber diameter, opening diameter and/or fiber spacing, and weave type/pattern will determine the surface area available for cell attachment and growth. In addition, when the cell culture matrix includes a stack, roll, or other arrangement of overlapping substrate, the packing density of the cell culture matrix will impact the surface area of the packed bed matrix. Packing density can vary with the packing thickness of the substrate material (e.g., the space needed for a layer of the substrate). For example, if a stack of cell culture matrix has a certain height, each layer of the stack can be said to have a packing thickness determined by dividing the total height of the stack by the number of layers in the stack. The packing thickness will vary based on fiber diameter and weave, but can also vary based the alignment of adjacent layers in the stack. Due to the three-dimensional nature of a woven layer, there is a certain amount of interlocking or overlapping that can occur between adjacent layers based on their alignment with one another. In a first alignment, the adjacent layers can be tightly nestled together, but in a second alignment, the adjacent layers can have zero overlap, such as when the lower-most point of the upper layer is in direct contact with the upper-most point of the lower layer. In practice, the amount of nesting can be impacted by both the translational and rotational alignment of the fiber patterns in adjacent layers. It may be desirable for certain applications to provide a cell culture matrix with a lower density packing of layers (e.g., when higher permeability is a priority) or a higher density of packing (e.g., when maximizing substrate surface area is a priority). According to one or more aspects of embodiments herein, the packing thickness can be from about 50 μm to about 1000 μm; about 100 μm to about 750 μm; about 125 μm to about 600 μm; about 150μm to about 500 μm; about 200 μm to about 400 μm; about 200 μm to about 300 μm. There ranges are provided by way of example only, and embodiments can include packing thicknesses outside of these ranges based on the chosen substrate, packing of the fixed bed, bioreactor design, and application.
The above structural factors can determine the available surface area of a cell culture matrix, whether of a single layer of cell culture substrate or of a cell culture matrix having multiple layers of substrate. The “effective surface area,” as used herein, is the total surface area of fibers in a portion of substrate material that is available for cell attachment and growth. Unless stated otherwise, references to “surface area” refer to this effective surface area. According to embodiments, a single woven mesh substrate layer with a diameter of, for example, 6 cm may have an effective surface area of about 50 cm2 to about 90 cm2; about 53 cm2 to about 81 cm2; about 68 cm2; about 75 cm2; or about 81 cm2, depending on the fiber size, arrangement of fibers/openings within the substrate, and obviously the size of the substrate layer itself. These ranges of effective surface area are provided for example only, and some embodiments may have different effective surface areas. The cell culture matrix can also be characterized in terms of porosity, as discussed in the Examples herein.
The substrate mesh can be fabricated from monofilament or multifilament fibers of polymeric materials compatible in cell culture applications, including, for example, polystyrene, polyethylene terephthalate, polycarbonate, polyvinylpyrrolidone, polybutadiene, polyvinylchloride, polyethylene oxide, polypyrroles, and polypropylene oxide. Mesh substrates may have a different patterns or weaves, including, for example knitted, warp-knitted, or woven (e.g., plain weave, twilled weave, dutch weave, five needle weave). Aspects of embodiments also include filaments made of any other suitable material for forming the porous structure and that are then coated with materials compatible with cell culture applications.
The surface chemistry of the mesh filaments may need to be modified to provide desired cell adhesion properties. Such modifications can be made through the chemical treatment of the polymer material of the mesh or by grafting cell adhesion molecules to the filament surface. Alternatively, meshes can be coated with thin layer of biocompatible hydrogels that demonstrate cell adherence properties, including, for example, collagen or Matrigel®. Alternatively, surfaces of filament fibers of the mesh can be rendered with cell adhesive properties through the treatment processes with various types of plasmas, process gases, and/or chemicals known in the industry. In one or more embodiments, however, the mesh is capable of providing an efficient cell growth surface without surface treatment.
The three-dimensional quality of the substrates according to embodiments of this disclosure provides increased surface area for cell attachment and proliferation compared to a planar 2D surface of comparable size. This increased surface area aids in the scalable performance achieved by embodiments of this disclosure. For process development and process validation studies, small-scale bioreactors are often required to save on reagent cost and increase experimental throughput. Embodiments of this disclosure are applicable to such small-scale studies, but can be scaled-up to industrial or production scale, as well. Because of the plug-type perfusion flow in a packed bed, the same flow rate expressed in ml/min/cm2 of cross-sectioned packed bed surface area can be used in smaller-scale and larger-scale versions of the bioreactor. A larger surface area allows for higher seeding density and higher cell growth density. According to one or more embodiments, the cell culture substrate described herein has demonstrated cell seeding densities of up to 22,000 cells/cm2 or more. For reference, the Corning HyperFlask® has a seeding density on the order of 20,000 cells/cm2 on a two-dimensional surface. As used herein, “plug-type perfusion flow” or “plug flow” refers to laminar flow through the bioreactor having a fixed bed according to embodiments herein, where the flow through any cross-section of the fixed bed perpendicular to the flow direction proceeds at the same rate across the cross section.
Another advantage of the higher surface areas and high cell seeding or growing densities is that the cost of the embodiments disclosed herein can be the same or less than competing solution. Specifically, the cost per cellular product (e.g., per cell or per viral genome) can be equal to or less than other packed bed bioreactors.
Thus, there are multiple factors of the fixed bed substrate that can impact the cell culture process, including the packing density, surface chemistry, and effective surface area, as well as the nature of fluid flow through and within the packed bed. By using a structurally defined culture matrix of sufficient rigidity, high-flow-resistance uniformity across the matrix or packed bed is achieved. According to various embodiments, the matrix can be deployed in flexible and scalable multilayer substrate arrangements. This flexibility eliminates diffusional limitations and provides uniform delivery of nutrients and oxygen to cells attached to the matrix. In addition, the open matrix lacks any cell entrapment regions in the packed bed configuration, allowing for complete cell harvest with high viability at the end of culturing. The matrix also delivers packaging uniformity for the packed bed, and enables direct scalability from process development units to large-scale industrial bioprocessing unit. The ability to directly harvest cells from the packed bed eliminates the need of resuspending a matrix in a stirred or mechanically shaken vessel, which would add complexity and can inflict harmful shear stresses on the cells. Further, the high packing density of the cell culture matrix yields high bioprocess productivity in volumes manageable at the industrial scale.
The geometry of the mesh substrate layers is designed to allow efficient and uniform flow through one or multiple substrate layers. In addition, the structure of the matrix can accommodate fluid flow through the matrix in multiple orientations. For example, the direction of bulk fluid flow can be perpendicular to the major side surfaces of the first and second substrate layers. However, the matrix can also be oriented with respect to the flow such that the sides of the substrate layers are parallel to the bulk flow direction. In addition to fluid flow being perpendicular or parallel to the first and second sides of the mesh layers, the matrix can be arranged with multiple pieces of substrate at intermediate angles, or even in random arrangements with respect to fluid flow. This flexibility in orientation is enabled by the essentially isotropic flow behavior of the woven substrate. In contrast, substrates for adherent cells in existing bioreactors do not exhibit this behavior and instead their packed beds tend to create preferential flow channels and have substrate materials with anisotropic permeability. The flexibility of the matrix of the current disclosure allows for its use in various applications and bioreactor or container designs while enabling better and more uniform permeability throughout the bioreactor vessel.
The cell culture substrate can be used within a bioreactor vessel, according to one or more embodiments. For example, the substrate can be used in a packed bed bioreactor configuration, or in other configurations within a three-dimensional culture chamber. However, embodiments are not limited to a three-dimensional culture space, and it is contemplated that the substrate can be used in what may be considered a two-dimensional culture surface configuration, where the one or more layers of the substrate lay flat, such as within a flat-bottomed culture dish, to provide a culture substrate for cells. Due to contamination concerns, the vessel can be a single-use vessel that can be disposed of after use.
A cell culture system is provided, according to embodiments, in which the cell culture matrix is used within a culture chamber of a bioreactor vessel.
In
The cell culture matrix can be arranged in multiple configurations within the culture chamber depending on the desired system. For example, in one or more embodiments, the system includes one or more layers of the substrate with a width extending across the width of a defined cell culture space in the culture chamber. Multiple layers of the substrate may be stacked in this way to a predetermined height. As discussed above, the substrate layers may be arranged such that the first and second sides of one or more layers are perpendicular to a bulk flow direction of culture media through the defined culture space within the culture chamber, or the first and second sides of one or more layers may be parallel to the bulk flow direction. In one or more embodiments, the cell culture matrix includes one or more substrate layers at a first orientation with respect to the bulk flow, and one or more other layers at a second orientation that is different from the first orientation. For example, various layers may have first and second sides that are parallel or perpendicular to the bulk flow direction, or at some angle in between.
In one or more embodiments, the cell culture system includes a plurality of discrete pieces of the cell culture substrate in a packed bed configuration, where the length and or width of the pieces of substrate are small relative to the culture chamber. As used herein, the pieces of substrate are considered to have a length and/or width that is small relative to the culture chamber when the length and/or width of the piece of substrate is about 50% or less of the length and/or width of the culture space. Thus, the cell culture system may include a plurality of pieces of substrate packed into the culture space in a desired arrangement. The arrangement of substrate pieces may be random or semi-random, or may have a predetermined order or alignment, such as the pieces being oriented in a substantially similar orientation (e.g., horizontal, vertical, or at an angle between 0° and 90° relative to the bulk flow direction).
The “defined culture space,” as used herein, refers to a space within the culture chamber occupied by the cell culture matrix and in which cell seeding and/or culturing is to occur. The defined culture space can fill approximately the entirety of the culture chamber, or may occupy a portion of the space within the culture chamber. As used herein, the “bulk flow direction” is defined as a direction of bulk mass flow of fluid or culture media through or over the cell culture matrix during the culturing of cells, and/or during the inflow or outflow of culture media to the culture chamber.
In one or more embodiments, the cell culture matrix is secured within the culture chamber by a fixing mechanism. The fixing mechanism may secure a portion of the cell culture matrix to a wall of the culture chamber that surrounds the matrix, or to a chamber wall at one end of the culture chamber. In some embodiments, the fixing mechanism adheres a portion of the cell culture matrix to a member running through the culture chamber, such as member running parallel to the longitudinal axis of the culture chamber, or to a member running perpendicular to the longitudinal axis. However, in one or more other embodiments, the cell culture matrix may be contained within the culture chamber without being fixedly attached to the wall of the chamber or bioreactor vessel. For example, the matrix may be contained by the boundaries of the culture chamber or other structural members within the chamber such that the matrix is held within a predetermined area of the bioreactor vessel without the matrix being fixedly secured to those boundaries or structural members.
When multiple layers of substrate are stacked face-to-face as shown in
For each modeled configuration in
In addition to the modeled porosity range, porosity was measured using real packed beds of PET woven mesh substrate. The measurements were made using one hundred disks, each with a diameter of 22.4 mm, stacked with random alignment. The total weight of the 100-disk stack was 5.65±0.2 g. Volume of the PET material of the stack was calculated, assuming a PET density of 1.38 g/cm3, using the following formula:
Thus, the PET volume VPET of 5.65 g of PET (for 100 disks of 22.4 mm diameter) was calculated to be 4.1 ml. The total volume Vtotal of the stack, including the PET volume VPET and the volume of the open space within the stack, was then calculated using the following formula:
The 100-disk stack had a stack height of 25±1 mm. Thus, with a disk diameter of 22.4 mm, Vtotal was found to be 9.85 ml. Accordingly, porosity of the stacked bed can be calculated using the following:
Using Equation 3 and the above values, the porosity was calculated to be 58.4%, which is within the range predicted by the model.
As discussed above, in the loose-packed configuration, fibers in layers of the fixed bed are aligned. It follows that the openings in the layers will also be aligned if the substrate materials in the layers are the same. Thus, if viewing a stack of substrates in this loose-packed configuration in plan view, it will be possible to see through the aligned openings in the stack.
However, in addition to translational shifts between layers in a fixed bed, it is also possible for rotational misalignment. It should be noted that both translational and rotational alignment can be factures of the fabrication of the substrate material itself (e.g., when individual layers are cut from a larger sheet) or from shifting between layers in the fixed bed (e.g., shifting that can occur during handling or assembly of a bioreactor, or once the fixed bed bioreactor is fully assembled). While strict manufacturing and assembling tolerances can accommodate for and reduce such shifts, such precision adds complexity and cost to the process.
To appreciate the impact that rotational alignment of substrate layers can have on the fixed bed properties,
If there is an angle of rotation between two layers, particularly for the lower angles such as 5° to 10° in
According to embodiments, a cell culture matrix is provided where each layer of the plurality of substrate layers is rotated about the center of the layer relative to an immediately neighboring layer in the stack such that an orientation of fibers in one layer of the plurality of substrate layers is different from an orientation of fibers in an immediately adjacent layer of the plurality of substrate layers. The difference in orientation can be measured by an angle of rotation of the fibers in one layer relative to another layer. A difference in the orientation of fibers in the one layer and the immediately adjacent layer can be, in some embodiments, about 5° or more, about 10° or more, about 15° or more, about 20° or more, about 25° or more, about 30° or more, or about 40° or more, and less than about 90°, about 85° or less, about 80° or less, about 75° or less, about 65° or less, about 60° or less, or about 50° or less. In some particular embodiments, the difference in the orientation is about 45°. In embodiments, the difference in the orientation is from about 40° to about 50°.
However, the precise degree of rotational alignment described above can be difficult. It requires steps be taken to align the mesh during reactor assembly and mechanical features to hold the alignment during handling, shipping and application. These extra steps and mechanical features will add extra costs and risks. Therefore, embodiments of this disclosure include fixed beds for cell culture that achieve uniform flow without requiring these costly measures to ensure precise rotational alignment.
According to embodiments of this disclosure, a fixed bed is provided having at least two different types of substrate materials stacked together in the same cell culture bed. In embodiments, the at least two different substrates are alternately stacked (e.g., Substrate A, Substrate B, Substrate A, Substate B, etc.). The at least two different types of substrate material can be different in one or more physical dimensions. For example, they may be different in fiber diameter, opening diameter, fiber spacing, or fiber direction. Embodiments using different types of substate material provide several advantages, including: no specific alignment is required during reactor assembly; no mechanical features are required in the vessel to hold the mesh in place; minimized variation in packed bed porosity or density; and improved flow uniformity in a packed bed reactor. The term “hybrid substrate,” “hybrid mesh,” or “hybrid fixed bed” are sometimes used herein to refer to a substrate matrix or fixed bed that contains at least two different types of substrate material, as discussed above.
In one or more preferred embodiments, the two different types of substrate have a different fiber spacing. The relationship of the fiber spacings of two different can be expressed as a ratio of the fiber spacing of the first mesh to the fiber spacing of the second mesh. Embodiments include at least two types of substrate of mesh with a fiber spacing ratio of at least about 1.1 and at most about 2.0, 2.5, 3.5, 4.0, 4.5, and 5.0; of a fiber spacing ratio of about 1.2 to about 4.0; or about 1.2 to about 2.0. According to embodiments with a fiber spacing ratio, it is not necessary to control or hold the layers to maintain a specific alignment. This can be demonstrated by modeling the flow patterns through stacks of substrate layers with different fiber spacing ratios, for example, as discussed below.
To demonstrate the impact of mesh alignment on flow uniformity and the benefit of using hybrid meshes, a simplified sinusoidal model can simulate the periodical change of flow resulting from passing a layer of mesh. The mesh is a woven pattern of two groups of parallel fibers (a first group of fibers running in parallel in a first direction, and a second group of fibers running in parallel in a second direction). As a basic model, a serial parallel cylinder is used to simulate the first group of fibers running in a first direction.
The resistance of a porous material, such as the series of cylinders 700, to fluid flow can be calculated from the flow rate using Equation 4, which is proportional to the reciprocal of flow rate, where R is the flow resistance, P is the pressure, and U is the flow rate. This reciprocal of the sinusoidal equation is used to represent the relative changes of flow resistance at different locations along the cylinder array.
To build on the model, a woven mesh 900 is modeled as two cylinder arrays 902, 904 stacked one over another and running orthogonally to each other, as shown in
The same approach can now be applied to simulate the flow rate distribution when the two meshes have varying degrees of rotation relative to one another. For example,
To address this nonuniformity issue, embodiments of this disclose include combining of at least two different types of mesh in a stack. For example, the at least two mesh materials can be stacked in an alternating manner, as discussed herein. To demonstrate the improvement in flow uniformity according to such embodiments, the same simulation can be used as discussed above. For example,
When the fiber spacing ratio between the two mesh layers is 1.2, as in
The bioreactor vessel optionally includes one or more outlets capable of being attached to inlet and/or outlet means. Through the one or more outlets, liquid, media, or cells can be supplied to or removed from the chamber. A single port in the vessel may act as both the inlet and outlet, or multiple ports may be provided for dedicated inlets and outlets.
The fixed bed cell culture matrix of embodiments of this disclosure can consist of woven cell culture mesh substrate(s) without any other form of cell culture substrate disposed in or interspersed with the cell culture matrix. That is, the woven cell culture mesh substrate of embodiments of this disclosure are effective cell culture substrates without requiring the type of irregular, non-woven substrates used in existing solution or without any separate and distinct structures or spacers used between layers (e.g., such as those used to create fluid flow channels between layers of substrate). This enables cell culture systems of simplified design and construction, while providing a high-density cell culture substrate with the other advantages discussed herein related to flow uniformity, harvestability, etc.
As discussed herein, the cell culture substrates and bioreactor systems provided offer numerous advantages. For example, the embodiments of this disclosure can support the production of any of a number of viral vectors, such as AAV (all serotypes) and lentivirus, and can be applied toward in vivo and ex vivo gene therapy applications. The uniform cell seeding and distribution maximizes viral vector yield per vessel, and the designs enable harvesting of viable cells, which can be useful for seed trains consisting of multiple expansion periods using the same platform. In addition, the embodiments herein are scalable from process development scale to production scale, which ultimately saves development time and cost. The methods and systems disclosed herein also allow for automation and control of the cell culture process to maximize vector yield and improve reproducibility. Finally, the number of vessels needed to reach production-level scales of viral vectors (e.g., 1016 to 1018 AAV VG per batch) can be greatly reduced compared to other cell culture solutions.
Embodiments are not limited to the vessel rotation about a central longitudinal axis. For example, the vessel may rotate about an axis that is not centrally located with respect to the vessel. In addition, the axis of rotation may be a horizonal or vertical axis.
“Wholly synthetic” or “fully synthetic” refers to a cell culture article, such as a microcarrier or surface of a culture vessel, that is composed entirely of synthetic source materials and is devoid of any animal derived or animal sourced materials. The disclosed wholly synthetic cell culture article eliminates the risk of xenogeneic contamination.
“Include,” “includes,” or like terms means encompassing but not limited to, that is, inclusive and not exclusive.
“Users” refers to those who use the systems, methods, articles, or kits disclosed herein, and include those who are culturing cells for harvesting of cells or cell products, or those who are using cells or cell products cultured and/or harvested according to embodiments herein.
“About” modifying, for example, the quantity of an ingredient in a composition, concentrations, volumes, process temperature, process time, yields, flow rates, pressures, viscosities, and like values, and ranges thereof, or a dimension of a component, and like values, and ranges thereof, employed in describing the embodiments of the disclosure, refers to variation in the numerical quantity that can occur, for example: through typical measuring and handling procedures used for preparing materials, compositions, composites, concentrates, component parts, articles of manufacture, or use formulations; through inadvertent error in these procedures; through differences in the manufacture, source, or purity of starting materials or ingredients used to carry out the methods; and like considerations. The term “about” also encompasses amounts that differ due to aging of a composition or formulation with a particular initial concentration or mixture, and amounts that differ due to mixing or processing a composition or formulation with a particular initial concentration or mixture.
“Optional” or “optionally” means that the subsequently described event or circumstance can or cannot occur, and that the description includes instances where the event or circumstance occurs and instances where it does not.
The indefinite article “a” or “an” and its corresponding definite article “the” as used herein means at least one, or one or more, unless specified otherwise.
Abbreviations, which are well known to one of ordinary skill in the art, may be used (e.g., “h” or “hrs” for hour or hours, “g” or “gm” for gram(s), “mL” for milliliters, and “rt” for room temperature, “nm” for nanometers, and like abbreviations).
Specific and preferred values disclosed for components, ingredients, additives, dimensions, conditions, and like aspects, and ranges thereof, are for illustration only; they do not exclude other defined values or other values within defined ranges. The systems, kits, and methods of the disclosure can include any value or any combination of the values, specific values, more specific values, and preferred values described herein, including explicit or implicit intermediate values and ranges.
Unless otherwise expressly stated, it is in no way intended that any method set forth herein be construed as requiring that its steps be performed in a specific order. Accordingly, where a method claim does not actually recite an order to be followed by its steps or it is not otherwise specifically stated in the claims or descriptions that the steps are to be limited to a specific order, it is in no way intended that any particular order be inferred.
It will be apparent to those skilled in the art that various modifications and variations can be made without departing from the spirit or scope of the disclosed embodiments. Since modifications, combinations, sub-combinations and variations of the disclosed embodiments incorporating the spirit and substance of the embodiments may occur to persons skilled in the art, the disclosed embodiments should be construed to include everything within the scope of the appended claims and their equivalents.
This application claims the benefit of priority under 35 U.S.C. § 119 of U.S. Provisional Application Ser. No. 63/284,153 filed on Nov. 30, 2021, the content of which is relied upon and incorporated herein by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2022/050202 | 11/17/2022 | WO |
Number | Date | Country | |
---|---|---|---|
63284153 | Nov 2021 | US |